Skip to main content
Erschienen in: Diabetologia 6/2006

01.06.2006 | Article

A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2

Erschienen in: Diabetologia | Ausgabe 6/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

We describe a novel model of insulin-deficient diabetes with a single copy of the gene encoding insulin 1 (Ins1) and no gene encoding insulin 2 (Ins2).

Materials and methods

We constructed five lines of mice: mice with two copies of Ins1 (NOD Ins1+/+,Ins2−/−), mice with a single copy of Ins1 (NOD Ins1+/−,Ins2−/−), mice with two copies of Ins2 (NOD Ins1−/−,Ins2+/+), mice with a single copy of Ins2 (NOD Ins1−/−,Ins2+/−) and NOD Ins1+/−,Ins2−/− mice with a transgene encoding B16:Ala proinsulin.

Results

By 10 weeks of age, all male NOD Ins1+/−,Ins2−/− mice were diabetic, whereas all female NOD Ins1+/−,Ins2−/− were not diabetic (p<0.0001). In contrast, neither male nor female NOD Ins1−/−,Ins2+/− with a single copy of Ins2 (rather than single copy of Ins1) developed early diabetes and no mice with two copies of either gene developed early diabetes. Islets of the diabetic male NOD Ins1+/−,Ins2−/− at this early age had no lymphocyte infiltration. Instead there was heterogeneous (between islet cells) weak staining for insulin. Although only male NOD Ins1+/−,Ins2−/− mice developed diabetes, both male and female NOD Ins1+/−,Ins2−/− mice had markedly decreased insulin content. In NOD Ins1+/+,Ins2−/−, there was also a significant decrease in insulin content, whereas NOD Ins1−/−,Ins2+/+ mice, and even NOD Ins1−/−,Ins2+/− mice, were normal. Male NOD Ins1+/−,Ins2−/− mice were completely rescued from diabetes by introduction of a transgene encoding proinsulin. On i.p. insulin tolerance testing, male mice had insulin resistance compared with female mice.

Conclusions/interpretation

These results suggest that Ins1 is a ‘defective gene’ relative to Ins2, and that the mouse lines created provide a novel model of sex-dimorphic insulin-deficient diabetes.
Literatur
1.
Zurück zum Zitat Soares MB, Schon E, Henderson A et al (1985) RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon. Mol Cell Biol 5:2090–2103PubMed Soares MB, Schon E, Henderson A et al (1985) RNA-mediated gene duplication: the rat preproinsulin I gene is a functional retroposon. Mol Cell Biol 5:2090–2103PubMed
2.
Zurück zum Zitat Moriyama H, Abiru N, Paronen J et al (2003) Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci USA 100:10376–10381PubMedCrossRef Moriyama H, Abiru N, Paronen J et al (2003) Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the nonobese diabetic mouse. Proc Natl Acad Sci USA 100:10376–10381PubMedCrossRef
3.
Zurück zum Zitat Thebault-Baumont K, Dubois-Laforgue D, Krief P et al (2003) Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 111:851–857PubMed Thebault-Baumont K, Dubois-Laforgue D, Krief P et al (2003) Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J Clin Invest 111:851–857PubMed
4.
Zurück zum Zitat Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223PubMedCrossRef Nakayama M, Abiru N, Moriyama H et al (2005) Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435:220–223PubMedCrossRef
5.
Zurück zum Zitat Nakayama M, Moriyama H, Abiru N et al (2004) Establishment of native insulin-negative NOD mice and the methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene. Ann N Y Acad Sci 1037:193–198PubMedCrossRef Nakayama M, Moriyama H, Abiru N et al (2004) Establishment of native insulin-negative NOD mice and the methodology to distinguish specific insulin knockout genotypes and a B:16 alanine preproinsulin transgene. Ann N Y Acad Sci 1037:193–198PubMedCrossRef
6.
Zurück zum Zitat Yu L, Robles DT, Abiru N et al (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701–1706PubMedCrossRef Yu L, Robles DT, Abiru N et al (2000) Early expression of antiinsulin autoantibodies of humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 97:1701–1706PubMedCrossRef
7.
Zurück zum Zitat Leroux L, Desbois P, Lamotte L et al (2001) Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50(Suppl 1):S150–S153PubMedCrossRef Leroux L, Desbois P, Lamotte L et al (2001) Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. Diabetes 50(Suppl 1):S150–S153PubMedCrossRef
8.
Zurück zum Zitat Chentoufi AA, Polychronakos C (2002) Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51:1383–1390PubMedCrossRef Chentoufi AA, Polychronakos C (2002) Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes 51:1383–1390PubMedCrossRef
9.
Zurück zum Zitat Ueda H, Ikegami H, Yamato E et al (1995) The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38:503–508PubMedCrossRef Ueda H, Ikegami H, Yamato E et al (1995) The NSY mouse: a new animal model of spontaneous NIDDM with moderate obesity. Diabetologia 38:503–508PubMedCrossRef
10.
11.
Zurück zum Zitat Ikegami H, Fujisawa T, Ogihara T (2004) Mouse models of type 1 and type 2 diabetes derived from the same closed colony: genetic susceptibility shared between two types of diabetes. ILAR J 45:268–277PubMed Ikegami H, Fujisawa T, Ogihara T (2004) Mouse models of type 1 and type 2 diabetes derived from the same closed colony: genetic susceptibility shared between two types of diabetes. ILAR J 45:268–277PubMed
12.
Zurück zum Zitat Babaya N, Ikegami H, Fujisawa T et al (2005) Susceptibility to streptozotocin-induced diabetes is mapped to mouse chromosome 11. Biochem Biophys Res Commun 328:158–164PubMedCrossRef Babaya N, Ikegami H, Fujisawa T et al (2005) Susceptibility to streptozotocin-induced diabetes is mapped to mouse chromosome 11. Biochem Biophys Res Commun 328:158–164PubMedCrossRef
13.
Zurück zum Zitat Kulkarni RN, Almind K, Goren HJ et al (2003) Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528–1534PubMedCrossRef Kulkarni RN, Almind K, Goren HJ et al (2003) Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice. Diabetes 52:1528–1534PubMedCrossRef
14.
Zurück zum Zitat Pugliese A, Zeller M, Fernandez A Jr et al (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293–297PubMedCrossRef Pugliese A, Zeller M, Fernandez A Jr et al (1997) The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet 15:293–297PubMedCrossRef
15.
Zurück zum Zitat Vafiadis P, Bennett ST, Todd JA et al (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289–292PubMedCrossRef Vafiadis P, Bennett ST, Todd JA et al (1997) Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat Genet 15:289–292PubMedCrossRef
16.
Zurück zum Zitat Chen W, Bergerot I, Elliott JF et al (2001) Evidence that a peptide spanning the B–C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 167:4926–4935PubMed Chen W, Bergerot I, Elliott JF et al (2001) Evidence that a peptide spanning the B–C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol 167:4926–4935PubMed
17.
Zurück zum Zitat Brimnes MK, Jensen T, Jorgensen TN, Michelsen BK, Troelsen J, Werdelin O (2002) Low expression of insulin in the thymus of non-obese diabetic mice. J Autoimmun 19:203–213PubMedCrossRef Brimnes MK, Jensen T, Jorgensen TN, Michelsen BK, Troelsen J, Werdelin O (2002) Low expression of insulin in the thymus of non-obese diabetic mice. J Autoimmun 19:203–213PubMedCrossRef
Metadaten
Titel
A new model of insulin-deficient diabetes: male NOD mice with a single copy of Ins1 and no Ins2
Publikationsdatum
01.06.2006
Erschienen in
Diabetologia / Ausgabe 6/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0241-4

Weitere Artikel der Ausgabe 6/2006

Diabetologia 6/2006 Zur Ausgabe

Commentary

Digami too?

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.